Gene · 60485
Papers1,483
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,483
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microbiota-derived tryptophan metabolites indole-3-lactic acid is associated with intestinal ischemia/reperfusion injury via positive regulation of YAP and Nrf2. | J Transl Med | 2023 | 37072757 | PubTator, text mining | PubMed |
| Adaptive Regulation of Stopover Refueling during Bird Migration: Insights from Whole Blood Transcriptomics. | Genome Biol Evol | 2023 | 37067540 | PubTator, text mining | PubMed |
Serine/threonine kinase 3 promotes oxidative stress and mitochondrial damage in septic cardiomyopathy through inducing Kelch-like ECH-associated protein 1 phosphorylation and nuclear factor erythroid 2-related factor 2 degradation. | Int J Biol Sci | 2023 | 37056939 | PubTator, text mining | PubMed |
| Integrating AI/ML Models for Patient Stratification Leveraging Omics Dataset and Clinical Biomarkers from COVID-19 Patients: A Promising Approach to Personalized Medicine. | Int J Mol Sci | 2023 | 37047222 | PubTator, text mining | PubMed |
| USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis. | Cell Death Dis | 2023 | 37041150 | PubTator, text mining | PubMed |
| Mammalian sterile 20-like kinase 1 acts as a candidate biomarker of mortality of emergency surgical repair for acute type a aortic dissection. | BMC Cardiovasc Disord | 2023 | 37038132 | PubTator, text mining | PubMed |
| URB2 as an important marker for glioma prognosis and immunotherapy. | Front Pharmacol | 2023 | 37033651 | PubTator, text mining | PubMed |
| Novel KDM2B/SAV1 Signaling Pathway Promotes the Progression of Gastric Cancer. | Genet Res (Camb) | 2023 | 37033161 | PubTator, text mining | PubMed |
| Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial. | Breast Cancer Res Treat | 2023 | 37029329 | PubTator, text mining | PubMed |
| Advances in the potential roles of Cullin-RING ligases in regulating autoimmune diseases. | Front Immunol | 2023 | 37006236 | PubTator, text mining | PubMed |
| lncRNA-FMR6 directly binds SAV1 to increase apoptosis of granulosa cells in premature ovarian failure. | J Ovarian Res | 2023 | 37005611 | PubTator, text mining | PubMed |
| Myofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomes. | Front Cardiovasc Med | 2023 | 36998974 | PubTator, text mining | PubMed |
| Possible Future Avenues for Rheumatoid Arthritis Therapeutics: Hippo Pathway. | J Inflamm Res | 2023 | 36998323 | PubTator, text mining | PubMed |
| Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection. | Immunity | 2023 | 36996809 | PubTator, text mining | PubMed |
| Morpho-Functional Effect of a New Collagen-Based Medical Device on Human Gingival Fibroblasts: An In Vitro Study. | Biomedicines | 2023 | 36979765 | PubTator, text mining | PubMed |
| Pathogenesis of allergic diseases and implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36964157 | PubTator, text mining | PubMed |
| Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors. | J Med Chem | 2023 | 36946421 | PubTator, text mining | PubMed |
| The Hippo signaling pathway: from multiple signals to the hallmarks of cancers. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 36942989 | PubTator, text mining | PubMed |
| Investigation of Hippo pathway-related prognostic lncRNAs and molecular subtypes in liver hepatocellular carcinoma. | Sci Rep | 2023 | 36941336 | PubTator, text mining | PubMed |
| The Hippo signaling pathway in gastric cancer. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 36924251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60485/papers?page=9